Neurodegeneration, neuroinflammation & neurotherapy

All Items

• The role of virtual reality in the rehabilitation of individuals with Down Syndrome

  Maithily Murali, Priyanka Kumar, Muhammed Afsal K A

  484.1-484.8

• Bibliometric analysis on potential biomarkers for long COVID

  Xiangyu Liu, Takafumi Suematsu, Nobuyuki Sudo, Battuvshin Lkhagvasuren

  502.1-502.20

• Impact of rhythmic auditory stimulation on gait disturbances in individuals with progressive supranuclear palsy

  Priyadharshini Kumar, Nijidha Manshi, Vignesh Srinivasan, Sathya Siva, Ahalya S

  495.1-495.10

• Phospholipid biomarkers in the diagnosis of patients with Alzheimer's disease

  Rossi Geovo Robledo, Anibal Arteaga Noriega; Juan Habib Bendeck Soto; Johanna Andrea Gutierrez Vargas

  462.1-462.11

• Clinically confirmed tuberculous radiculomyelitis: a case report

  Mohammad Kurniawan, Tiara Kasih, David Pangeran, Kartika Maharani

  421.1-421.6

• A mini review on genes in stroke recovery: unveiling the genetic blueprint for rehabilitation therapies

  Nurhaziqah binti Ramlan, Eric Tzyy Jiann Chong

  476.1-476.12

• Effects of long-term tactile deprivation on anxiety-like behavior and c-Fos expression in elderly mice

  Gerardo Monroy-Alcantar, David Zarate-Lopez, Oscar Gonzalez-Perez, Veronica Lopez-Virgen

  444.1-444.9

• Optimizing functional recovery after sciatic nerve injury: A multidisciplinary approach

  Nurul Aini Binti Taib, Muhammad Danial Bin Che Ramli, Zolkapli Bin Eshak , Hussin Bin Muhammad

  371.1-371.11

• Zerumbone ameliorates neuroinflammation in LPS-induced SH-SY5Y cells, an in vitro model of neuropathic pain: targeting NO, IL-6, and TNF-α

  Noor Aishah Mohammed Izham, Enoch Kumar Perimal, Sharmili Vidyadaran, Hemabarathy Bharatham, Mohd Roslan Sulaiman

  374.1-374.13

• Analysis of lumbar dorsal spinal potentials evoked by electrical stimulation of the colon and their changes induced by high-frequency stimulation or ischemia in rats

  María Duarte, Mariangel Gallegos, América Arveláez, Antonio Eblen-Zajjur

  367.1-367.9

• “Frailty” in patients with Parkinsonian Spectrum Disorders: an observation from a tertiary care teaching hospital

  Himanshu Kaushal, Rajendra Kumar Sureka, Amit Kumar Agarwal

  319.1-319.7

• The impact of minocycline in inhibiting glial scar formation in rats with traumatic brain injury: A mini scoping review

  Donny Wisnu Wardhana, Husnul Khotimah, Tommy Alfandy Nazwar, Nurdiana Nurdiana

  329.1-329.9

• Platelets as mediators of neuropsychiatric and neurodegenerative diseases

  Vasiliki Konstantinidou, Dimitra Farmaki, Ioannis Chonianakis, Kallimachos Gratsos

  349.1-349.15

• Increasing serum HMGB1 as a potential biomarker of treatment-resistant epilepsy in children: A case series and literature review

  Andika Priamas Nugrahanto, Agung Triono, Kristy Iskandar, Veronica Wulan Wijayanti, Elisabeth Siti Herini

  318.1-318.8

• The chronic cerebral hypoperfusion model induces proinflammatory cascades in Alzheimer's disease

  Zahra Abedi, Hamidon Basri, Zurina Hassan, Liyana Najwa Inche Mat, Huzwah Khaza'ai, Razana Binti Mohd Ali

  315.1-315.13

• AfrAbia's silent struggle: Pesticides and Parkinson's disease unveiled

  Wael Mohamed

  353.1-353.4

• Default mode network perturbations in Alzheimer's disease: an fMRI study in Klang Valley, Malaysia

  Nur Hafizah Mohad Azmi , Subapriya Suppiah , Nur Shahidatul Nabila Ibrahim, Ibrahim Buhari, Vengkhata Priya Seriramulu , Mazlyfarina Mohamad , Thilakavathy Karuppiah , Nur Farhayu Omar, Normala Ibrahim, Rizzah Mazzuin Razali , Noor Harzana Harrun , Hakimah Mohammad Sallehuddin , Nisha Syed Nasser, Umar Ahmad

  284.1-284.14

• Gene expression analysis in plasma of patients with Alzheimer's disease

  Seda Kusoglu Gultekin, Irem Gulfem Albayrak, Yunus Diler, Ayse Destina Yalcin, Belkis Atasever Arslan

  302.1-302.9

• Neuroinflammation-induced neurodegeneration and associated microglia activation in Parkinson’s disease: a novel neurotherapeutic avenue

  Panlekha Rungruang, Veerawat Sansri, Morakot Sroyraya

  271.1-271.21

• Role of nanotechnology in therapeutics and diagnosis of Alzheimer’s disease

  Dhivya P Sundaram, Swathy Govindaswamy, Sobiya Mathiazhagan, Jayalakshmi Venugopal

  225.1-225.9

• Differential gene expression of blood-based ABCA9, CNOT8, SESN1, UCP3, MAP2K1 and DDIT4 in Alzheimer’s disease

  Ainon Zahariah Samsudin, Kalavathy Ramasamy, Siong Meng Lim, Ai Vyrn Chin, Maw Pin Tan, Shahrul Bahyah Kamaruzzaman, Baharudin Ibrahim, Abu Bakar Abdul Majeed

  262.1-262.14

• Comparison of deep learning convolutional neural networks method with conventional volume-based morphometry measurement of hippocampal volume in Alzheimer's disease

  Nur Shahidatul Nabila Ibrahim, Subapriya Suppiah, Buhari Ibrahim, Nur Hafizah Mohad Azmi, Vengkatha Priya Seriramulu, Mazlyfarina Mohamad, Marsyita Hanafi, Hakimah Mohammad Sallehuddin, Rizah Mazzuin Razali, Noor Harzana Harrun

  248.1-248.10

• The antidepressant-like effect of NevGro® Forte in chronic unpredictable mild stress (CUMS) model of depression in rats

  Zakirah Zainal Abidin, Juwita Junit, Muhammad Danial Che Ramli, Syntyche Seow Ling Sing, Poh Guat Cheng, Zolkapli Eshak, Mohamad Anuar Ahad, Hussin Muhammad

  261.1-261.16

• IoT-enabled solutions for Alzheimer's disease management: innovations and opportunities

  Muskan Thakur, Ajay Kumar, Indranath Chatterjee

  255.1-255.10

• Intravenous human dental pulp-derived mesenchymal stem cell therapy for ischemic stroke in rats: an analysis of functional and ischemic brain areas outcomes

  Gabriel Frizon Greggianin, Marco Antônio Stefani, Taís Malysz, Laura Elena Sperling

  237.1-237.11

• Rosmarinic acid-rich ethanolic extract of Orthosiphon stamineus ameliorates cognitive and hippocampal long-term potentiation in chronic cerebral hypoperfusion rat model

  Zurina Hassan, KKesevan Rajah Kumaran, Nelson Jeng-Yeou Chear, Siti Najmi Syuhadaa Bakar, Thaarvena Retinasamy, Saatheeyavaane Bhuvanendran, Amin Malik Abdul Majeed, Mohd. Farooq Shaikh, Iekhsan Othman

  196.1-196.16

• Interleukin 1 receptor antagonist and neurodegenerative diseases: the future treatment strategy

  Thaarvena Retinasamy, Mohd. Farooq Shaikh

  164

• COVID-19 and the central nervous system: What is the interplay?

  Noha M Abd El-Fadeal, Sara A Anber, Hoda A Elkot, Ghada Maged, Iman A Saeed, Marwa M Negm, Menna Allah Abdelsamad, Asmaa El-bakri , Wael Mohamed

  155

• Analysis of significance of mitochondrial dysfunction in the pathogenesis of diseases of the central nervous system

  Olena Petrivna Sokolik, Galina Olexandrivna Prozorova

  151

• Exploring the possibilities of using in vitro model for neuropathic pain studies

  Noor Aishah Mohammed Izham, Jasmine Siew Min Chia, Nur Khalisah Kaswan, Kavitha Sukirthalingam, Sharmili Vidyadaran, Hemabarathy Bharatham, Mohd Roslan Sulaiman, Enoch Kumar Perimal

  144

• The effect of an acute bout of high intensity intermittent exercise on neural growth factors in young adults: Sex differences

  Prachi Khandekar, Shweta Shenoy, Abhinav Sathe

  146

• Data on multiple post-translational modifications in Alzheimer's disease

  Sayali Chandrashekhar Deolankar, Shashanka G Koyangana, Arun H Patil, Yashwanth Subbannayya, Prashant Kumar Modi, T S Keshava Prasad

  153

• Inflammation in embryology: A review of neuroinflammation in spina bifida

  Singh Nivrenjeet, Siti Waheeda Mohd-Zin, Singh Nisheljeet, Abu Bakar Azizi, Kamalanathan Palaniandy, Mohd Firdaus-Raih, Mohd Hisam Muhamad Ariffin, Nicholas Daniel Edward Greene, Noraishah Mydin Abdul-Aziz

  132

• Development of a cognitive-based smartphone application for Malaysian Parkinson's disease patients: Exploring the possibility?

  Wael Mohamed, Shahedah Koya Kutty, Akram Khedher, Indranath Chatterjee

  126

• Insights of the pathophysiology of neurodegenerative diseases and the role of phytochemical compounds in its management

  Zurina Hassan, Raghava N. Sriramaneni

  1-10

• In vitro anti-cholinesterase activity and in vivo screening of Coccoloba uvifera, Mimusops elengi and Syzygium aqueum extracts on learning and memory function of chronic cerebral hypoperfusion rat

  Kesevan Rajah Kumaran, Habibah Abdul Wahab, Zurina Hassan

  1-13

• Chemical hypoxia in human pluripotent NT2 stem cell-derived neurons: Effect of hydroxamic acid and benzamide-based epigenetic drugs

  Rushita A Bagchi, Ashim K Bagchi, Ankita Salunke, Dipak K Hens, Pragna H Parikh

  12-19

• The potential of MLC901 (NeuroAiD II™), a traditional Chinese medicine

  Suhua Huang, Mingxia Lin, Xiaowei Pan, Qiwen Tan, Kai-Leng Tan

  18-24

• Prospective stem cell lines as in vitro neurodegenerative disease models for natural product research

  Nur Izzati Mansor, Nuratiqah Azmi, King Hwa Ling, Rozita Rosli, Zurina Hassan, Norshariza Nordin

  16-30

• Cholinergic modulation of hippocampal long-term potentiation in chronic cerebral hypoperfused rats

  Nor Fasihah Azam, Ryan Andrew Stanyard, Noorul Hamizah Mat, Zurina Hassan

  42-57